全球脂肪组织衍生干细胞 (ADSCS) 市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球脂肪组织衍生干细胞 (ADSCS) 市场 – 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

全球脂肪组织衍生干细胞 (ADSCS) 市场,按细胞系(人类脂肪组织衍生干细胞、大鼠脂肪组织衍生干细胞)、试剂(培养基、血清、试剂盒)、应用(再生医学、组织工程、细胞疗法、其他)、最终用户(生物技术公司、学术和研究机构)划分 - 行业趋势和预测到 2029 年。

脂肪组织来源干细胞 (ADSCS) 市场

脂肪组织来源干细胞 (ADSCS) 市场分析和规模

成人干细胞由脂肪组织产生,具有极佳的再生治疗潜力。脂肪组织来源的干细胞产量高于其他干细胞来源。皮肤、骨骼和软骨再生是利用脂肪组织产生的干细胞进行再生医学的几种方法。

Data Bridge Market Research 分析,脂肪组织衍生干细胞 (ADSCS) 市场预计在 2022 年至 2029 年的预测期内将经历 6.60% 的复合年增长率。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

脂肪组织来源干细胞 (ADSCS) 市场范围和细分      

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

细胞系(人类脂肪组织来源干细胞、大鼠脂肪组织来源干细胞)、试剂(培养基、血清、试剂盒)、应用(再生医学、组织工程、细胞疗法、其他)、最终用户(生物技术公司、学术和研究机构)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Lonza(美国)、ThermoFisher Scientific Inc.(美国)、Celprogen, Inc(美国)、iXCells Biotechnologies(美国)、Merck KGaA(德国)、Lifeline Cell Technology(美国)、AlloCure, Inc.(美国)、Antria, Inc.(美国)、Celgene Corporation(美国)、Celleris SA(西班牙)、Corestem, Inc.(韩国)、Cytori Therapeutics, Inc.(美国)、Intrexon, Inc.(美国)、Mesoblast Ltd.(澳大利亚)、Pluristem Therapeutics, Inc.(以色列)和 Tissue Genesis(美国) 

市场机会

  • Rise in regulatory approvals for adipose derived stem cell
  • Rise in private and public funding for stem cell-based research

Market Definition

The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.

Adipose Tissue Derived Stem Cells (ADSCS) Market Dynamics

Drivers

  • Increased potential demand from the cartilage

The market for adipose tissue-derived stem cells is expanding due to the development of stem cell-based research for efficient drug manufacture and expansion in biotech applied sciences (ADSCS). When compared to other alternative stem cells such bone marrow the approach used is far more productive. The adipose tissue-derived stem cells (ADSCS) market is anticipated to have increased potential demand from the cartilage and bone regeneration industry.

  • Utilisation of reagents to provide successful results

The utilisation of reagents to provide successful results for the stem cell business will drive market expansion. Reagent kits are used in the cell line experiments performed on humans and rats. Adipose tissue-derived stem cells (ADSCS) market growth is predicted to occur between 2022 and 2029 due to a number of causes.

Opportunities

Additionally, a rise in regulatory approvals for adipose derived stem cell targeted clinical trials globally, a rise in private and public funding for stem cell-based research, and a surge in partnerships and collaborations for the development of advanced stem cell line manufacturing technologies are all contributing to the market growth for adipose tissue derived stem cells.

Restraints/Challenges

Moral objections and stringent guidelines for handling experiments may serve as market restraints during a period of market expansion. Adipose tissue-derived stem cells (ADSCS) are ineffective at distinguishing between the tissues and organs of the human body, which could impede the market's expansion.

This adipose tissue derived stem cells (ADSCS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adipose tissue derived stem cells (ADSCS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Adipose Tissue Derived Stem Cells (ADSCS) Market Scope

The adipose tissue derived stem cells (ADSCS) market is segmented on the basis of cell line, reagents, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cell Line

  • Human Adipose Tissue-Derived Stem Cells
  • Rat Adipose Tissue-Derived Stem Cells

Reagents

  • Media
  • Sera
  • Kits

Application

  • Regenerative Medicine
  • Tissue Engineering
  • Cell Therapy
  • Others

End User

  • Biotechnology Companies
  • Academic
  • Research Institutes

Adipose Tissue Derived Stem Cells (ADSCS) Market Regional Analysis/Insights

The adipose tissue derived stem cells (ADSCS) market is analysed and market size insights and trends are provided by country, cell line, reagents, application and end user as referenced above.

The countries covered in the adipose tissue derived stem cells (ADSCS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the adipose tissue-derived stem cells (ADSCS) market due to the amplified research and development of stem cells and tissue engineering.

Asia-Pacific (APAC) is expected to cater potential market base for adipose tissue-derived stem cells (ADSCS) due to government support in China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Adipose Tissue Derived Stem Cells (ADSCS) Market Share Analysis

脂肪组织来源干细胞 (ADSCS) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对脂肪组织来源干细胞 (ADSCS) 市场的关注有关。

脂肪组织来源的干细胞 (ADSCS) 市场的一些主要参与者包括:

  • 龙沙(美国)
  • ThermoFisher Scientific Inc.(美国)
  • Celprogen, Inc(美国)
  • iXCells Biotechnologies(美国)
  • 默克集团(德国)
  • 生命线细胞技术公司(美国)
  • AlloCure, Inc.(美国)
  • Antria, Inc.(美国)
  • Celgene 公司 (美国)
  • Cellleris SA(西班牙)
  • Corestem, Inc. (韩国)
  • Cytori Therapeutics, Inc.(美国)
  • Intrexon, Inc.(美国)
  • Mesoblast Ltd. (澳大利亚)
  • Pluristem Therapeutics, Inc.(以色列)
  • Tissue Genesis(美国) 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America is the dominating region the Adipose Tissue Derived Stem Cells (ADSCS) Market.
The is the dominating region the Adipose Tissue Derived Stem Cells (ADSCS) Market growth rate is 6.60% by 2029
The Increased potential demand from the cartilage and Utilisation of reagents to provide successful results are the growth drivers of the Adipose Tissue Derived Stem Cells (ADSCS) Market.
The cell line, reagents, application and end user are the factors on which the Adipose Tissue Derived Stem Cells (ADSCS) Market research is based.
The major companies in the Adipose Tissue Derived Stem Cells (ADSCS) Market are Lonza (U.S.), ThermoFisher Scientific Inc. (U.S.), Celprogen, Inc (U.S.), iXCells Biotechnologies (U.S.), Merck KGaA (Germany), Lifeline Cell Technology (U.S.), AlloCure, Inc. (U.S.), Antria, Inc. (U.S.), Celgene Corporation (U.S.), Cellleris SA (Spain), Corestem, Inc. (South Korea), Cytori Therapeutics, Inc. (U.S.), Intrexon, Inc. (U.S.), Mesoblast Ltd. (Australia), Pluristem Therapeutics, Inc. (Israel), and Tissue Genesis (U.S.).